Loading…

Equal IgG Antibody Response to Pneumococcal Vaccination in All Stages of Human Immunodeficiency Virus Disease

To evaluate the immunogenicity and safety of a 23-valent pneumococcal vaccine in human immunodeficiency virus (HIV)-seropositive patients, 80 men and 18 women received 1 dose of the vaccine (Pneumo 23; Pasteur Mérieux MSD, Brussels). The total IgG antibody response against all 23 Streptococcus pneum...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of infectious diseases 1995-08, Vol.172 (2), p.551-553
Main Authors: Vandenbruaene, Marc, Colebunders, R., Mascart-Lemone, F., Haerden, Y., Van Hove, D., Peeters, M., Goeman, J., Van Royen, P., Avonts, D.
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To evaluate the immunogenicity and safety of a 23-valent pneumococcal vaccine in human immunodeficiency virus (HIV)-seropositive patients, 80 men and 18 women received 1 dose of the vaccine (Pneumo 23; Pasteur Mérieux MSD, Brussels). The total IgG antibody response against all 23 Streptococcus pneumoniae capsular antigens was measured. Antibody levels were expressed in arbitrary units per microliter, referring to a standard curve. Geometric mean titers of the total IgG capsular antibodies on the day of vaccination and 30–45 days later were compared. The ratios of titers after and before vaccination in patients with >500,200–500, and
ISSN:0022-1899
1537-6613
DOI:10.1093/infdis/172.2.551